Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Amundi Asset Management US Inc.

Amundi Asset Management US Inc. grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 220,933 shares of the medical equipment provider’s stock after purchasing an additional 16,926 shares during the quarter. Amundi Asset Management US Inc. owned approximately 0.19% of Intuitive Surgical worth $163,257,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Vantage Consulting Group Inc acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at about $25,000. Wealthcare Capital Management LLC acquired a new position in shares of Intuitive Surgical during the 1st quarter valued at about $25,000. Kistler Tiffany Companies LLC boosted its position in shares of Intuitive Surgical by 100.0% during the 1st quarter. Kistler Tiffany Companies LLC now owns 40 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 20 shares during the last quarter. Prestige Wealth Management Group LLC boosted its position in shares of Intuitive Surgical by 136.8% during the 4th quarter. Prestige Wealth Management Group LLC now owns 45 shares of the medical equipment provider’s stock valued at $37,000 after acquiring an additional 26 shares during the last quarter. Finally, Evolution Wealth Advisors LLC boosted its position in shares of Intuitive Surgical by 51.5% during the 1st quarter. Evolution Wealth Advisors LLC now owns 50 shares of the medical equipment provider’s stock valued at $37,000 after acquiring an additional 17 shares during the last quarter. 83.72% of the stock is currently owned by institutional investors.

Several research analysts have recently weighed in on the stock. Robert W. Baird boosted their price target on shares of Intuitive Surgical from $825.00 to $1,050.00 and gave the company an “outperform” rating in a research report on Wednesday. JPMorgan Chase & Co. upped their target price on shares of Intuitive Surgical from $900.00 to $1,000.00 and gave the company an “overweight” rating in a research report on Wednesday. Bank of America upped their target price on shares of Intuitive Surgical from $890.00 to $1,020.00 and gave the company a “neutral” rating in a research report on Wednesday. Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $960.00 to $1,060.00 and gave the company a “buy” rating in a research report on Wednesday, July 14th. Finally, upped their target price on shares of Intuitive Surgical from $862.00 to $939.00 and gave the company a “buy” rating in a research report on Wednesday, April 21st. Ten analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $929.50.

In other Intuitive Surgical news, Director Amal M. Johnson sold 2,500 shares of the stock in a transaction that occurred on Wednesday, May 12th. The shares were sold at an average price of $817.82, for a total value of $2,044,550.00. Following the transaction, the director now directly owns 6,223 shares in the company, valued at $5,089,293.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Reiter Kara Andersen sold 750 shares of the stock in a transaction that occurred on Friday, April 23rd. The shares were sold at an average price of $848.01, for a total transaction of $636,007.50. Following the completion of the transaction, the senior vice president now owns 5,594 shares in the company, valued at $4,743,767.94. The disclosure for this sale can be found here. Insiders sold 56,243 shares of company stock worth $48,517,488 over the last quarter. 0.90% of the stock is currently owned by insiders.

ISRG stock opened at $944.94 on Thursday. The stock’s 50 day moving average price is $884.05. Intuitive Surgical, Inc. has a fifty-two week low of $633.29 and a fifty-two week high of $987.27. The stock has a market capitalization of $111.89 billion, a price-to-earnings ratio of 70.62, a price-to-earnings-growth ratio of 8.31 and a beta of 1.05.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Monday, July 19th. The medical equipment provider reported $3.92 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.06 by $0.86. Intuitive Surgical had a net margin of 31.43% and a return on equity of 16.65%. The firm had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.26 billion. During the same period in the prior year, the firm earned $1.11 earnings per share. The business’s quarterly revenue was up 71.8% compared to the same quarter last year. On average, equities analysts predict that Intuitive Surgical, Inc. will post 12.26 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

See Also: What is the NASDAQ Stock Market?

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.